Skip to main content
padlock icon - secure page this page is secure

Enucleation of pancreatic neoplasms

Buy Article:

$69.00 + tax (Refund Policy)

Background:

Standard resections for benign and borderline neoplasms of the pancreas are associated with a significant risk of long‐term functional impairment, whereas enucleation preserves healthy parenchyma and pancreatic function. The aim of this study was to evaluate postoperative and long‐term oncological and functional results after pancreatic enucleation.

Methods:

Data collected prospectively from 61 consecutive patients who underwent pancreatic enucleation were analysed.

Results:

There were no deaths. A clinically significant pancreatic fistula was reported in 14 patients (23 per cent), and five patients (8 per cent) had a further operation for fistula‐related complications. The most common indication for surgery was endocrine neoplasm (38 patients; 62 per cent) and two patients (3 per cent) had a final histopathological diagnosis of malignant neoplasm. At a median follow‐up of 61 months no patient had developed tumour recurrence or exocrine insufficiency. Two elderly patients developed non‐insulin‐dependent diabetes.

Conclusion:

Enucleation is an effective procedure for the radical treatment of benign and borderline neoplasms of the pancreas, with good long‐term outcomes. Copyright © 2007 British Journal of Surgery Society Ltd. Published by John Wiley & Sons, Ltd.
No References
No Citations
No Supplementary Data
No Article Media
No Metrics

Document Type: Research Article

Publication date: October 1, 2007

More about this publication?
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more